Skip to content
Altius – Lifestyle
Author:
CDT Equity Inc.
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
March 18, 2026
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
March 12, 2026
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
March 5, 2026
←
Previous Page
1
2